Could the smell of roses prevent sudden death in epilepsy?
NCT ID NCT07116421
First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This early-phase study tests whether breathing in rose scent can reduce the number of times people with epilepsy stop breathing during seizures. Forty adults admitted to a hospital epilepsy monitoring unit will have their brain activity and breathing tracked for 48 hours, with rose scent diffused into their room for the second 24 hours. The goal is to see if this simple, pleasant smell can lower the risk of Sudden Unexpected Death in Epilepsy (SUDEP).
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
2-phenylethanol (rose scent) delivered via essential oil diffuser
What this could lead to
If it works, this could point toward a simple, non-invasive way to reduce breathing problems during seizures and potentially lower the risk of sudden death in epilepsy.
What could go wrong
This is a very early, small trial with only 40 participants and no control group. The effect may be small or absent, and some people may find the scent unpleasant or irritating.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for EPILEPSY are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Vanderbilt University Medical Center
RECRUITINGNashville, Tennessee, 37232, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
Contact Email: •••••@•••••
Contact
Contact